Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10968496 | Vaccine | 2013 | 7 Pages |
Abstract
⺠Novel iDNA platform was used for vaccination against VEEV alphavirus. ⺠Less than 10 ng of pTC83 iDNA initiated replication of the vaccine virus in vitro. ⺠BALB/c mice vaccinated with a single dose of pTC83 iDNA have seroconverted. ⺠After challenge with VEEV, all pTC-83-vaccinated mice were protected. ⺠Proposed platform allows conversion of live attenuated virus into DNA vaccine.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Irina Tretyakova, Igor S. Lukashevich, Pamela Glass, Eryu Wang, Scott Weaver, Peter Pushko,